Int. braz j urol. vol.36 número6
Texto
Documentos relacionados
Neste contexto, “A qualidade da informação financeira previsional como instrumento de avaliação do pressuposto da continuidade: o caso das empresas municipais” vem
malignant pathologies The authors concluded that in patients at high risk of prostate cancer, circulating VEGF levels have no clinical role in deciding which patients should
Conclusions: Patients with PSA recurrence and a negative post-radiation biopsy have a high chance of persistent local disease, progression, and death from prostate
High-risk prostate cancer includes advanced clinical stage (> T2), Gleason score 8-10 or PSA level > 20ng/mL.. Men with high-risk prostate cancer experience
Background: High-intensity focused ultrasound (HIFU) is an emerging treatment for select patients with local- ized prostate cancer (PCa).. Objectives: To report the oncologic outcome
MEASUREMENT OF PLASMA LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROSTATE CANCER PATIENTS: RELATIONSHIP WITH CLINICAL STAGE, GLEASON SCORE, PROSTATE VOLUME, AND
CONCLUSION: Percutaneous cryoablation of the prostate is a safe minimally invasive treatment, but it has poor PSA-free survival outcomes in high-risk prostate cancer
Pretreatment tumor volume estimation based on total serum PSA in patients with localized prostate